Lawsuits against the manufacturer of the chemotherapy drug Taxotere involve allegations of increased risk of permanent hair loss. Attorneys of those claiming to be adversely affected by Taxotere state that if their clients had adequate warnings of the permanent hair loss risk, a different drug might have been prescribed that is more effective without the risk of permanent hair loss. Like many other drug and medical device cases, few settlements or verdicts have been announced in Taxotere cases. At least one batch of Taxotere has been recalled, but the drug remains available. Contact me if you have suffered from permanent hair loss as a result of chemotherapy. You may have been administered Taxotere.